4//SEC Filing
SADOWSKI PETER L 4
Accession 0001140361-11-028828
CIK 0001016169other
Filed
May 18, 8:00 PM ET
Accepted
May 19, 4:40 PM ET
Size
8.0 KB
Accession
0001140361-11-028828
Insider Transaction Report
Form 4
SADOWSKI PETER L
Senior Vice President
Transactions
- Award
Stock Option (right to buy)
2011-05-17+51,000→ 809,000 totalExercise: $1.66Exp: 2021-05-16→ Common Stock (51,000 underlying) - Award
Common Stock
2011-05-17+32,000→ 133,221 total
Footnotes (5)
- [F1]Represents the target number of shares Dr. Sadowski may receive pursuant to the terms of the performance stock unit award made to Dr. Sadowski under the 2008 Equity Compensation Plan if certain performance goals are attained over the three-year period beginning January 1, 2011 and ending December 31, 2013 and Dr. Sadowski continues in employment with the Company through that period.
- [F2]Not applicable
- [F3]Represents the total number of shares owned plus all outstanding unearned or unvested shares granted less the number of shares used to fulfill tax withholding obligations when certain shares previously granted became taxable after they were earned or vested.
- [F4]Represents grant of options to purchase shares of common stock, par value $0.01 per share, issued under the Antares Pharma, Inc. 2008 Equity Compensation Plan.
- [F5]The options vest in equal quarterly installments over three years.
Documents
Issuer
ANTARES PHARMA, INC.
CIK 0001016169
Entity typeother
Related Parties
1- filerCIK 0001187592
Filing Metadata
- Form type
- 4
- Filed
- May 18, 8:00 PM ET
- Accepted
- May 19, 4:40 PM ET
- Size
- 8.0 KB